SECTION 1
Historical Context & Motivation
For centuries, the mechanisms underlying heredity remained profoundly mysterious—farmers and breeders recognized that traits passed from parent to offspring, but the governing rules eluded systematic description. The prevailing theory of blending inheritance held that parental contributions mixed irreversibly, much like paint colors, yet this model failed to explain why certain traits could skip generations and reappear unaltered. It was the meticulous work of an Augustinian friar in a monastery garden that provided the first quantitative framework for understanding hereditary transmission, a framework that remains the bedrock of clinical genetics and a recurring focus on the USMLE Step 1.
1866 • Mendel Publishes His Experiments
1900 • Rediscovery of Mendel's Laws
1905 • Pedigree Analysis Enters Medicine
1953 • DNA Structure Elucidated
Present • Genomic Medicine
The fundamental question Mendel answered—how are discrete traits transmitted across generations?—translates directly into the clinical question physicians face: given a family history of a genetic disorder, what is the probability that a patient or their offspring will be affected? This lesson equips you to answer that question using Mendel's laws, Punnett square analysis, and systematic pedigree interpretation.
SECTION 2
Core Principles & Definitions
Mendelian inheritance rests on a set of principles that describe how alleles—alternative forms of a gene at a given locus—are transmitted from parents to offspring. Before diving into specific inheritance patterns, it is essential to establish a shared vocabulary. A genotype refers to the specific allelic combination at a locus, whereas the phenotype is the observable trait that results from that genotype interacting with the environment. An individual carrying two identical alleles at a locus is homozygous; one carrying two different alleles is heterozygous.
Law of Segregation
Law of Independent Assortment
Law of Dominance
Pedigree Symbols & Conventions
Carrier vs. Affected
KEY TAKEAWAY
SECTION 3
Visual Explanation — Punnett Squares & Inheritance Patterns
The Punnett square is the most intuitive tool for predicting the genotypic and phenotypic ratios of offspring from a given cross. In the diagram below, a monohybrid cross between two heterozygous carriers (Aa × Aa) is illustrated—the classic scenario for autosomal recessive disease. Each parent contributes either the dominant allele (A) or the recessive allele (a) with equal probability, yielding the expected 1:2:1 genotypic ratio and 3:1 phenotypic ratio.
HIGH-YIELD USMLE POINT
SECTION 4
Mathematical Framework — Probability in Genetics
Genetic probability relies on two fundamental rules from combinatorics that allow you to calculate the likelihood of specific genotypic outcomes. These rules apply whether you are working through a Punnett square, analyzing a pedigree, or predicting the recurrence risk for genetic counseling. Mastering these rules is essential because many USMLE genetics questions are fundamentally probability problems in a clinical disguise.
MULTIPLICATION RULE (AND RULE)
The probability of two independent events both occurring equals the product of their individual probabilities. Example: probability that a child inherits allele 'a' from mother AND allele 'a' from father = ½ × ½ = ¼.
ADDITION RULE (OR RULE)
The probability of either of two mutually exclusive events occurring equals the sum of their individual probabilities. Example: probability that a child is Aa OR AA from an Aa × Aa cross = ½ + ¼ = ¾.
HARDY-WEINBERG CARRIER FREQUENCY
For autosomal recessive conditions: q² = frequency of affected individuals, q = frequency of the recessive allele, p = frequency of the dominant allele (p = 1 − q), and 2pq = carrier frequency. This equation bridges population genetics with pedigree analysis.
CONDITIONAL PROBABILITY (BAYESIAN)
Bayes' theorem is used in pedigree analysis to update the prior probability of a genotype given new information (e.g., phenotypic observation of offspring). It is the mathematical basis for the "2/3 carrier probability" calculation.
The multiplication rule is applied whenever you need to calculate the probability of a specific combination of independent events—for instance, the chance that three consecutive children from carrier parents are all unaffected. The addition rule comes into play when you need the probability of at least one of several mutually exclusive outcomes. In clinical genetics, these rules combine with Hardy-Weinberg equilibrium to estimate the risk of a couple having an affected child when only the population disease prevalence is known.
SECTION 5
Detailed Breakdown — Inheritance Pattern Recognition
Systematic pedigree analysis requires pattern recognition. Each mode of inheritance—autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, and mitochondrial—produces a characteristic pattern of affected individuals across generations. Recognizing these patterns rapidly is a critical skill for USMLE questions and clinical practice. The diagram below summarizes the key distinguishing features of the five major Mendelian inheritance patterns.
| Feature | Autosomal Dominant | Autosomal Recessive | X-Linked Recessive |
|---|---|---|---|
| Vertical transmission | Yes (every generation) | No (skips generations) | Often skips (through carrier ♀) |
| Sex ratio affected | M = F | M = F | M >> F |
| Male-to-male | Possible | Possible | Never |
| Consanguinity effect | Minimal | Strongly increases risk | Minimal |
| Risk to offspring (Aa × aa) | 50% | 25% (Aa × Aa) | 50% of sons (carrier ♀ × normal ♂) |
Comparison of the three most commonly tested Mendelian inheritance patterns
SECTION 6
Worked Example — Cystic Fibrosis Risk Calculation
A couple seeks genetic counseling. The woman's brother has cystic fibrosis (autosomal recessive, CFTR gene). The man has no family history of CF. The disease prevalence among Caucasians is approximately 1/2,500. What is the probability that their first child will have cystic fibrosis?
Cystic Fibrosis Recurrence Risk
- 1
Step 1 — Determine the woman's carrier probability
The woman's brother has CF (genotype: ff). This means both of her parents must be carriers (Ff × Ff). Since the woman is unaffected, her possible genotypes are FF or Ff. Using the Punnett square from the Aa × Aa cross, the ratio of unaffected genotypes is 1 FF : 2 Ff. Therefore, the probability that the woman is a carrier is 2/3.P(woman is carrier) = 2/3 - 2
Step 2 — Determine the man's carrier probability using Hardy-Weinberg
The disease frequency q² = 1/2,500, so q = 1/50. Since p ≈ 1 (because q is very small), the carrier frequency is 2pq ≈ 2 × 1 × 1/50 = 1/25. The man has no family history, so we use the population carrier frequency.P(man is carrier) = 1/25 - 3
Step 3 — Calculate the probability that both are carriers AND the child is affected
Using the multiplication rule: both must be carriers AND both must pass the recessive allele. If both are carriers (Ff × Ff), the probability of an affected child is 1/4. Therefore: P = P(woman carrier) × P(man carrier) × P(child affected | both carriers) = 2/3 × 1/25 × 1/4.P = 2/3 × 1/25 × 1/4 = 2/300 = 1/150 - 4
Step 4 — Interpret the result clinically
The couple has approximately a 1 in 150 (≈ 0.67%) chance that their first child will have cystic fibrosis. This risk is considerably higher than the general population risk of 1/2,500 due to the woman's positive family history. Genetic counseling would also discuss the option of carrier testing for both partners to refine this estimate.Risk ≈ 1/150 (0.67%)
CLINICAL PEARL
SECTION 7
Complications of Mendelian Inheritance
While Mendel's laws provide an elegant framework, clinical genetics encounters numerous phenomena that modify or complicate simple Mendelian predictions. Recognizing these deviations is essential because the USMLE tests your ability to distinguish classic patterns from these modifiers. The table below summarizes the most high-yield exceptions you should be prepared to identify.
| Modifier | Definition | Clinical Example |
|---|---|---|
| Incomplete penetrance | Not all individuals with a disease genotype express the phenotype. Penetrance is the percentage of carriers who manifest disease. | BRCA1 mutations: ~70% lifetime penetrance for breast cancer; retinoblastoma gene: ~90% penetrance |
| Variable expressivity | Individuals with the same genotype exhibit different severity of the phenotype. | Neurofibromatosis type 1: ranges from café-au-lait spots alone to severe plexiform neurofibromas |
| Pleiotropy | A single gene affects multiple organ systems or phenotypic traits. | Marfan syndrome (FBN1): affects skeleton, eyes, and cardiovascular system |
| Anticipation | Disease onset is earlier or more severe in successive generations due to trinucleotide repeat expansion. | Huntington disease (CAG repeats), Fragile X syndrome (CGG repeats), Myotonic dystrophy (CTG repeats) |
| Imprinting | Phenotype depends on whether the allele is inherited from mother or father due to epigenetic silencing. | Deletion of 15q11-13: Prader-Willi (paternal) vs. Angelman (maternal) |
| Locus heterogeneity | Mutations in different genes produce the same phenotype. | Osteogenesis imperfecta (COL1A1 or COL1A2); Retinitis pigmentosa (>80 genes) |
High-yield modifiers of Mendelian inheritance for USMLE Step 1
KEY TAKEAWAY
SECTION 8
Connection to Complex & Non-Mendelian Inheritance
While Mendelian inheritance governs single-gene (monogenic) disorders, many clinically significant conditions—including diabetes, hypertension, coronary artery disease, and most psychiatric disorders—follow multifactorial (complex) inheritance patterns. These conditions result from the combined effects of multiple genes and environmental influences. Understanding where Mendelian genetics ends and complex genetics begins is crucial for interpreting both clinical and board-exam scenarios.
| Feature | Mendelian (Single Gene) | Multifactorial (Complex) |
|---|---|---|
| Number of genes | One major gene | Multiple genes + environment |
| Pedigree pattern | Clear-cut ratios (3:1, 1:1, etc.) | Familial clustering but no clear ratios |
| Recurrence risk | Predictable (25%, 50%, etc.) | Empiric risk (2–10% for first-degree relatives) |
| Concordance in MZ twins | ~100% | < 100% (varies; e.g., ~50% for schizophrenia) |
| Environmental influence | Minimal (gene determines phenotype) | Major (lifestyle, diet, exposures) |
| Population prevalence | Usually rare (< 1/1,000) | Common (diabetes, HTN, CAD) |
Mendelian vs. multifactorial inheritance
The study of Mendelian inheritance also provides the foundation for understanding pharmacogenomics—how single-gene polymorphisms affect drug metabolism. For example, variations in the CYP2D6 gene determine whether a patient is a poor, intermediate, extensive, or ultra-rapid metabolizer of codeine and many antidepressants. As genomic medicine advances, the ability to connect pedigree-level observations to molecular diagnoses becomes increasingly central to clinical practice. The USMLE tests this bridging concept, requiring you to move fluidly between population genetics, pedigree interpretation, and molecular biology.
SECTION 9
Practice Problems
Question 1: CONCEPTUAL
Show answer
Question 2: BASIC CALCULATION
Show answer
Question 3: INTERMEDIATE
Show answer
Question 4: APPLIED
Show answer
Question 5: CRITICAL THINKING
Show answer
SUMMARY
Mendelian Inheritance & Pedigrees — Summary
Summary
Mendelian inheritance is governed by three foundational laws: the Law of Segregation (each gamete receives one allele), the Law of Independent Assortment (genes on different chromosomes assort independently), and the Law of Dominance (dominant alleles mask recessive alleles in heterozygotes). These principles enable prediction of offspring genotype and phenotype ratios using Punnett squares and the multiplication and addition rules of probability.
Pedigree analysis is the clinical application of Mendelian genetics. Key pattern recognition rules include: autosomal dominant traits appear in every generation with equal sex distribution; autosomal recessive traits skip generations and are increased by consanguinity; X-linked recessive disorders affect males predominantly with no male-to-male transmission. The 2/3 carrier probability for unaffected siblings of an affected individual (autosomal recessive) and the Hardy-Weinberg equation for estimating population carrier frequency are among the most commonly tested concepts on the USMLE. Modifiers such as incomplete penetrance, variable expressivity, and anticipation explain deviations from classic Mendelian patterns and bridge the gap to complex, multifactorial inheritance.